• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of bmcamBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Complementary and Alternative Medicine
BMC Complement Altern Med. 2010; 10: 9.
Published online Feb 28, 2010. doi:  10.1186/1472-6882-10-9
PMCID: PMC2839964

Effect of ethnomedicinal plants used in folklore medicine in Jordan as antibiotic resistant inhibitors on Escherichia coli

Abstract

Background

Escherichia coli occurs naturally in the human gut; however, certain strains that can cause infections, are becoming resistant to antibiotics. Multidrug-resistant E. coli that produce extended-spectrum β lactamases (ESBLs), such as the CTX-M enzymes, have emerged within the community setting as an important cause of urinary tract infections (UTIs) and bloodstream infections may be associated with these community-onsets. This is the first report testing the antibiotic resistance-modifying activity of nineteen Jordanian plants against multidrug-resistant E. coli.

Methods

The susceptibility of bacterial isolates to antibiotics was tested by determining their minimum inhibitory concentrations (MICs) using a broth microdilution method. Nineteen Jordanian plant extracts (Capparis spinosa L., Artemisia herba-alba Asso, Echinops polyceras Boiss., Gundelia tournefortii L, Varthemia iphionoides Boiss. & Blanche, Eruca sativa Mill., Euphorbia macroclada L., Hypericum trequetrifolium Turra, Achillea santolina L., Mentha longifolia Host, Origanum syriacum L., Phlomis brachydo(Boiss.) Zohary, Teucrium polium L., Anagyris foetida L., Trigonella foenum-graecum L., Thea sinensis L., Hibiscus sabdariffa L., Lepidium sativum L., Pimpinella anisum L.) were combined with antibiotics, from different classes, and the inhibitory effect of the combinations was estimated.

Results

Methanolic extracts of the plant materials enhanced the inhibitory effects of chloramphenicol, neomycin, doxycycline, cephalexin and nalidixic acid against both the standard strain and to a lesser extent the resistant strain of E. coli. Two edible plant extracts (Gundelia tournefortii L. and Pimpinella anisum L.) generally enhanced activity against resistant strain. Some of the plant extracts like Origanum syriacum L.(Labiateae), Trigonella foenum- graecum L.(Leguminosae), Euphorbia macroclada (Euphorbiaceae) and Hibiscus sabdariffa (Malvaceae) did not enhance the activity of amoxicillin against both standard and resistant E. coli. On the other hand combinations of amoxicillin with other plant extracts used showed variable effect between standard and resistant strains. Plant extracts like Anagyris foetida (Leguminosae) and Lepidium sativum (Umbelliferae) reduced the activity of amoxicillin against the standard strain but enhanced the activity against resistant strains. Three edible plants; Gundelia tournefortii L. (Compositae) Eruca sativa Mill. (Cruciferae), and Origanum syriacum L. (Labiateae), enhanced activity of clarithromycin against the resistant E. coli strain.

Conclusion

This study probably suggests possibility of concurrent use of these antibiotics and plant extracts in treating infections caused by E. coli or at least the concomitant administration may not impair the antimicrobial activity of these antibiotics.

Background

E. coli occurs naturally in the human gut; however, certain strains that can lead to infections are becoming resistant to antibiotics. From the late 1990s, multidrug-resistant Enterobacteriaceae (mostly Escherichia coli) that produce extended-spectrum β lactamases (ESBLs), such as the CTX-M enzymes, have emerged within the community setting as an important cause of urinary tract infections (UTIs) [1]. Recent reports have also described ESBL-producing E. coli as a cause of bloodstream infections associated with these community-onsets of UTI [2]. Such development of drug resistance in human pathogens against commonly used antibiotics has necessitated a search for new antimicrobial substances, chemotherapeutic agents, and agrochemicals that combine antimicrobial efficacy with low toxicity, and minor environmental impact.

Natural products offer an untold diversity of chemical structures. These natural compounds often serve as lead molecules whose activities can be enhanced by manipulation through combinations with chemicals and by synthetic chemistry [3,4].

An important source of natural products is plants which are rich in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, and flavonoids. These metabolites have been found in vitro to have antimicrobial properties [5-14]. Interest in medicinal plants has increased in recent years. This interest has lead to the discovery of new biologically-active molecules by the pharmaceutical industry and the adoption of crude extracts of plants for self-medication by the general public [3,4].

Many plants have been evaluated not only for their inherent antimicrobial activity, but also for their action as a resistance-modifying agent [15-18]. The enhancement of antibiotic activity or the reversal of antibiotic resistance by natural or synthetic non-conventional antibiotics has lead to the classification of these compounds as modifiers of antibiotic activity.

In this study we screened nineteen Jordanian plants, known to have antimicrobial activity in folk medicine [19-23], for their possible effect as modifiers of antibiotic activity against bacteria. Some of them are edible and considered safe. In general, these plants are used in folk medicine in the treatment of skin diseases, gastrointestinal tract diseases and respiratory problems. The plants used in this study and their properties are listed in Table Table1.1. Relative few studies have been carried out to evaluate the antimicrobial properties of these plants. Two strains of E. coli were used, a resistant strain, which was isolated from a local hospitalized patient, and a standard laboratory strain from the ATCC culture collection.

Table 1
Uses and properties of ethnomedicinal plants used in this study.

Methods

Plant material

Plants were either collected from the field or purchased from the local market (Table (Table1).1). The taxonomic identity of the plants was confirmed by comparing collected voucher specimens with those of known identity which are located in the Herbarium of the Dept. of Biological Science, Faculty of Science, University of Jordan in Amman.

Preparation of plant extracts

Air dried and finely powdered plant materials were extracted in a Soxhlet with two liters of methanol for 4 hrs, except for Capparis spinosa, which was extracted for 10 hrs. Methanol is a semi polar solvent and is used in extracting polar and apolar compounds simultaneously.

Solvents were then evaporated under reduced pressure and the extracts were conserved in tightly sealed glass vials. Euphorbia macroclada latex was obtained by cutting and squeezing the stem of the plant and examined directly.

Determination of antimicrobial activity

Microorganisms

A resistant strain of Escherichia coli was isolated from hospitalized patients from the Jordan University Hospital and its identity confirmed by biochemical tests. A standard laboratory strain of E. coli ATCC 8739 was used as control.

Preparation of inoculum

Stock cultures were maintained at 4°C on slopes of nutrient agar. Cultures for experiments were prepared by transferring a sample from the stock cultures into Mueller-Hinton broth (MHB) and incubating without agitation for 24 hrs at 37°C. The cultures were diluted with fresh Mueller-Hinton broth to achieve optical densities corresponding to 2.0 × 106 colony forming units (CFU/ml).

Antibiotics

Antibiotics used in this study were amoxicillin, (Merck), chloramphenicol, (Fluka), neomycin, (Hikma Pharmaceutical Manufacture Co.), cephalexin, clarithromycin, doxycycline, (Arab Pharmaceutical Manufacture Co) and Nalidixic acid (Fluka).

Minimum inhibitory concentration (MIC) determination for antibiotics

The MIC of the antibiotics was tested by the NCCLS broth microdilution reference method [24] with some modification. MIC tests were performed in 96 flat bottom microtiter plates (TPP, Switzerland). Each test well was filled with 100 μl nutrient broth. A sample (100 μl) of the antibiotic stock solution was added to the first test well and mixed. A series of dilutions was then prepared across the plate using a micropipette. The concentration ranges used to determine MICs were: Amoxycillin 0.12-32 μg/ml, Chlormphenicol 0.5- 30 μg/ml, Nalidixic acid 0.12-16 μg/ml, Cephalexin 0.5-42 μg/ml, Neomycin 2-256 μg/ml, Doxycycline 0.5-128 μg/ml and Clarithromycin 0.5-160 μg/ml. A 10 μl aliquot of the standard laboratory strain of E. coli ATCC 8739 was used to inoculate each microtiter plate well to achieve a final inoculum size of 5 × 105 CFU/ml.

Positive growth controls (well with overnight culture, nutrient broth and bacterial inoculum but without antibiotic) and negative controls (well with broth but without inoculum) were also prepared and incubated at 37° for 24 hrs.

Microbial growth in the test wells was detected as turbidity, visualized by naked eyes, relative to the negative and positive controls. MICs were calculated as follows:

equation image

Where

C n: Concentration at well number n, where no turbidity was observed.

C (n + 1): Concentration at well number (n + 1), where turbidity was observed.

MIC determination was carried out in triplicate (in same 96-well plate) and repeated twice for each bacteria and each tested agent. MICs values are shown in Table Table22.

Table 2
Minimum inhibitory concentrations of the antibiotics used in the study against standard laboratory strain of Escherichia coli ATCC 8739

Modification of antibiotic activity by plant extracts

Antibiotics were added to 18.5 ml molten nutrient agar to give half their MIC concentrations (Table (Table2).2). Dried plant extracts were dissolved in absolute ethanol to give a stock solution of 8 mg/ml. To determine the effect of the plant extract on the activity of the antibiotics, 0.5 ml of the ethanolic solution of the plant extract and 1 ml of the bacterial suspension was added to the nutrient agar containing the antibiotic to give an inoculum size of 5 × 10 3 CFU/ml cells and a final concentration of 200 μg/ml of the plant extract in the nutrient gar. The medium was mixed thoroughly, poured in a plate and then incubated at 37°C for 24 hrs. The number of colonies on each plate (N) was determined. At the same time, for each combination control counts (N0) which were determined by adding an inoculum size of 5 × 103 CFU/ml to molten nutrient agar containing 0.5 ml of ethanol and incubating at 37°C for 24 hrs. The percentage growth was then calculated by reference to the control count (considered as 100% growth) as follows

equation image

Where

N0 is the number of colonies on the control count of the blank

N is the colony count after exposure to combinations of the antibiotic and the plant extract

Control and test counts were determined twice for each bacterial strain and for each combination of antibiotic and plant extract.

The percentage growth was determined twice for each bacterial strain and for each combination of antibiotic and plant extract. The test count was always referred to the control (100% growth) count done at the same time. The average percentage is presented in Tables Tables33 &4.

Table 3
Effect of each plant extract combined with various antibiotics on growth of resistant E. coli.
Table 4
Effect of each plant extract combined with various antibiotics on growth of standard E. coli.

Preliminary experiments were carried out to confirm that plant extracts at 200 μg/ml, the antibiotics at half their MICs, and the 0.5 ml of ethanol did not inhibit growth of the challenge inoculum. These experiments were also repeated every time the modification of antibiotic activity by plant extracts was studied.

Results and Discussion

Plants used in this study are mentioned in Table Table1.1. Some of these plants are edible used either as food or in the folk medicine and are considered safe. The rest of the plants are not commonly used by the laymen, but are used by herbalists in folk medicine [19-23].

The bacteria used in this study were resistant and standard strains of E. coli. In addition to being an essential component of the gut flora, E. coli is an etiologic agent for both hospital and community-acquired infections in humans [2,25,26]. As with other bacterial pathogens, this bacterium can develop single and multidrug resistance to several antimicrobial families; consequently, antimicrobial treatment of invasive E. coli infections can be challenging. The antibiotics used in this study were chosen to represent different groups of antibiotics. Their concentrations were chosen to be approximately half their MIC (Table (Table2)2) to guarantee that the effect produced is due to the combination and not to the effect of the antibiotic alone.

The effects of the plant extracts on the growth of the antibiotics against the resistant and standard strains of E. coli are shown in Tables Tables33 and and4.4. Samples of the plants without combinations allowed 100% growth of the inoculum at level of 200 μg ml-1. Methanolic extracts of the plant materials significantly enhanced the inhibitory effects of chloramphenicol, neomycin, doxycycline, cephalexin and nalidixic acid (Table (Table33 and and4)4) against both the standard strain and to a lesser extent the resistant strain of E. coli. The effects varied significantly according to the antibiotic and the E. coli strain. The efficacy of the combinations in enhancing the antibacterial activity was generally greater against the standard strain where for some combinations no growth was detected (e.g. combinations of chloramphenicol, neomycin, doxycycline, cephalexin and nalidixic acid with almost all plant material used). On the other hand, plant materials enhanced activity of these antibiotics to a slightly lesser extent against the resistant strain (Table (Table33).

Some of the plant materials used in the study like Origanum syriacum L. (Labiateae), Trigonella foenum- graecum L.(Leguminosae), Euphorbia macroclada (Euphorbiaceae) and Hibiscus sabdariffa (Malvaceae) did not enhance the activity of amoxicillin against both standard and resistant E. coli (Table (Table33 and and4).4). On the other hand combinations of amoxicillin with other plant materials used showed variable effect between standard and resistant strains. Plant material like Anagyris foetida (Leguminosae) and Lepidium sativum (Umbelliferae) reduced the activity of amoxicillin against the standard strain however; they enhanced the activity against resistant strains (Tables (Tables33 &4).

Activity of cephalexin on the resistant strain was enhanced when used in combination with all plant materials (Table (Table3).3). The enhancement of the activity of cephalexin was more pronounced against the standard strain with all the plant materials used (Table (Table4).4). Of note is the fact that cephalexin is one of the first generation cephalosporins which do not normally have activity against E. coli. This might indicate that the plant material allowed better penetration of the drug through the outer layers to the cell wall, which is the target site for this antibiotic. This might also indicate that the plant material acts by another mechanism such as blocking the inhibitory effect of the enzymes.

Combinations of clarithromycin with three edible plants; Gundelia tournefortii L. (Compositae) Eruca sativa Mill. (Cruciferae), and Origanum syriacum L. (Labiateae), enhanced activity against the resistant E. coli strain (Table (Table3).3). However, combinations of this antibiotic with the other plant materials used did not enhance the inhibitory effect significantly against both standard and resistant strains.

The main mechanisms of resistance to antibiotics used in this study are active efflux and enzymatic inactivation [27]. Several studies have been performed to identify drugs interfering with these pumps, called resistance modifying agents [28]. Plant products, as ethanol extracts of Mentha arvensis, are known to affect the efflux system of an E. coli multiresistant to aminoglycosides, inhibiting these resistance mechanism [29]. This strategy is named "herbal shotgun" or "Synergistic multi-target effects" and refers to the use of herbals and drugs in a multi targeted approach, due to the fact that mono or multi-extract combinations affect not one but several targets, cooperating in an agonistic-synergistic way. This approach is not exclusive for extract combinations, but combinations between single natural products or extracts with chemosynthetic or antibiotics are possible too [30-32].

The observed variations in the activity of the combinations on the two strains indicate structural changes in standard and resistant strains. The observed variations in the effects when using different plants and plants belonging to the same families suggests different structure and mechanism of action for the active substance (s) in these plants (Table (Table33 and and44).

Conclusion

On the basis of the evidence obtained from this study some general conclusions can be drawn regarding the effect of the plant material on the activity of antibiotics used. Different plants sometimes belong to the same family, have different effects on the activity of antibiotics. Neomycin, chloramphenicol, doxycycline and cephalexin can be given advantageously with almost all the plant materials mentioned earlier with few exceptions (e.g. with Trigonella foenum-graecum), however, clinical trials are required to support that. The activity of amoxicillin and clarithromycin were the least enhanced by the presence of the plant material against Gram negative bacteria. Doxycycline activity was the most significantly improved when combined with the plant material when tested against both bacterial strains. Nalidixic acid activity was improved significantly when combined with all plant materials and tested on standard strains. On the other hand, its activity on the resistant strain was slightly improved using the same combinations.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

RMD has carried out the microbiology experimental part such as inoculum preparation and antimicrobial evaluation. TAA collected the ethnomedicinal plants and performed the experimental part which involved plant material such as extraction. Both authors evaluated the results and corrected the manuscript for publication. Both authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1472-6882/10/9/prepub

Acknowledgements

The authors are grateful to Professor Sally Bloomfield , BPharm PhD , The Old Dairy Cottage, Woodhouse Lane, Montacute, Somerset TA15 6XL, for her valuable effort in editing the manuscript. This work has been done during the sabbatical leave (2007) offered to Dr. Rula M. Darwish by the University of Jordan. The authors are grateful to the Deanship of Scientific Research, University of Jordan, Amman - Jordan for the support of this work. Thanks also to The Arab Pharmaceutical Manufacture for the supply of the Antibiotics.

References

  • Pitout J, Laupland K. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. The Lancet Infectious Diseases. 2008;8:159–166. doi: 10.1016/S1473-3099(08)70041-0. [PubMed] [Cross Ref]
  • Pitout J, Laupland K. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. The Lancet Infectious Diseases. 2008;8:159–166. doi: 10.1016/S1473-3099(08)70041-0. [PubMed] [Cross Ref]
  • Houghton P. The Role of Plants in Traditional Medicine and Current Therapy. The Journal of Alternative and Complementary Medicine. 1995;1:131–143. doi: 10.1089/acm.1995.1.131. [PubMed] [Cross Ref]
  • Baker D, Mocek U, Garr C. In: Biodiversity: new leads for pharmaceutical and agrochemical industries. Wrigley SK, Hayes MA, Thomas R, Chrystal EJT, Nicholson N, editor. The Royal Society of Chemistry, Cambridge: United Kingdom; 2000. Natural products vs. combinatorials: a case study; pp. 66–72.
  • Bouzada Maria LM, Fabri Rodrigo L, Mauro Nogueira, Konno Tatiana UP, Duarte Gizele G, Elita Scio. Antibacterial, cytotoxic and phytochemical screening of some traditional medicinal plants in Brazil. Pharmaceutical Biology. 2009;47:44–52. doi: 10.1080/13880200802411771. [Cross Ref]
  • Alam Sher. Antimicrobial Activity of Natural Products from Medicinal Plants. Gomal Journal of Medical Sciences. 2009;7:72–78.
  • Osawa K, Matsumoto T, Maruyama T, Takiguchi T, Okuda K, Takazoe I. Studies on the antibacterial activity of plant extracts and their constituents against periodontopathic bacteria. Bulletin of Tokyo Dental College. 1990;31:17–21. [PubMed]
  • Chakraborty A, Brantner AH. Antibacterial steroid alkaloids from the stem bark of Holarrhena pubescens. Journal of Ethnopharmacology. 1999;68:339–344. doi: 10.1016/S0378-8741(99)00119-1. [PubMed] [Cross Ref]
  • Cowan M. Plant Products as Antimicrobial Agents. Clinical Microbiology Reviews. 1999;12:564–582. [PMC free article] [PubMed]
  • Vivanco JM, Savary BJ, Flores HE. Characterization of two novel type I ribosome-inactivating proteins from the storage roots of the Andean crop Mirabilis expansa. Plant Physiology. 1999;119:1447–1456. doi: 10.1104/pp.119.4.1447. [PMC free article] [PubMed] [Cross Ref]
  • Bisignano G, Sanogo R, Marino A, Aquino R, Dangelo V, German MP, De Pasquale R, Pizza C. Antimicrobial activity of Mitracarpus scaber extract and isolated constituents. Letters in Applied Microbiology. 2000;30:105–108. doi: 10.1046/j.1472-765x.2000.00692.x. [PubMed] [Cross Ref]
  • Habibi Z, Eftekhar F, Samiee K, Rustaiyan A. Structure and antibacterial activity of new labdane diterpenoid from Salvia leriaefolia. Journal of Natural Products. 2000;63:270–271. doi: 10.1021/np990287h. [PubMed] [Cross Ref]
  • Setzer WN, Setzer MC, Bates RB, Jakes BR. Biologically active triterpenoid of Syncarpia glomulifera bark extract from Paluma, North Queensland, Australia. Planta Medica. 2000;66:176–177. doi: 10.1055/s-2000-11129. [PubMed] [Cross Ref]
  • Al-Momani W, Abu-Basha E, Janakat S, Nicholas RAJ, Ayling RD. In vitro antimycoplasmal activity of six Jordanian medicinal plants against three Mycoplasma species. Tropical Animal Health and Production. 2007;39:515–519. doi: 10.1007/s11250-007-9033-1. [PubMed] [Cross Ref]
  • Iinuma M, Tsuchiya H, Sato M, Yokoyama J, Ohyama M, Ohkawa Y, Tanaka T, Fujiwara S, Fujii T. Flavanones with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. Journal of Pharmacy and Pharmacology. 1994;46:892–895. [PubMed]
  • Kim H, Park SW, Park JM, Moon KH, Lee CK. Screening and isolation of antibiotic resistant inhibitors from herb materials I -Resistant Inhibition of 21 Korean Plants. Natural Product Science. 1995;1:50–54.
  • Aburjai T, Darwish RM, Al-Khalil S, Mahafza A, Al-Abbadi A. Screening of antibiotic resistant inhibitors from local plant materials against two different strains of Pseudomonas aeruginosa. Journal of Ethnopharmacology. 2001;76:39–44. doi: 10.1016/S0378-8741(01)00206-9. [PubMed] [Cross Ref]
  • Darwish RM, Aburjai T, Al-Khalil S, Mahafza A, Al-Abbadi A. Screening of ntibiotic resistant inhibitors from local plant materials against two different strains of Staphylococcus aureus. Journal of Ethnopharmacology. 2002;79:359–364. doi: 10.1016/S0378-8741(01)00411-1. [PubMed] [Cross Ref]
  • Al-Khalil S. A Survey of plants used in Jordanian traditional medicine. International Journal of Pharmacognosy. 1995;33:317–323. doi: 10.3109/13880209509065385. [Cross Ref]
  • Oran SA, Al-Eisawi DM. Check-list of medicinal plants in Jordan. Dirasat. 1998;25:84–112.
  • Abu-rmaileh B, Afifi FU. Treatment with medicinal plants in Jordan. Dirasat (In Arabic) 2000;27:53–74.
  • Sawsan Abu-Hamdah, Afifi Fatma U, Mayyadah Shehadeh, Sami Khalid. Simple Quality-Control Procedures for Selected Medicinal Plants Commonly Used in Jordan. Pharmaceutical Biology. 2005;43:1–7. doi: 10.1080/13880200590903228. [Cross Ref]
  • Aburjai Talal, Hudaib Mohammad, Tayyem Rabab, Yousef Mohammed, Qishawi Maher. Ethnopharmacological survey of medicinal herbs in Jordan, the Ajloun Heights region. Journal of Ethnopharmacology. 2007;110:294–304. doi: 10.1016/j.jep.2006.09.031. [PubMed] [Cross Ref]
  • National Committee for Clinical Laboratory Standards (NCCLS) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard, 5th edn 2000. M7-A5; Vol.20, No.2, replaces M7-A4, Vol.17, No.2.
  • Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997-1998. Clinical Infectious Diseases. 2000;30:454–60. doi: 10.1086/313710. [PubMed] [Cross Ref]
  • Oteo J, Lázaro E, de Abajo FJ, Baquero F, Campos J. Antimicrobial-resistant invasive Escherichia coli in Spain. Emerging Infectious Diseases. 2005;11:546–53. [PMC free article] [PubMed]
  • Lomovskaya Olga, Watkins Will. Inhibition of Efflux Pumps as a Novel Approach to Combat Drug Resistance in Bacteria. Journal of Molecular Microbiology and. Biotechnology. 2001;3:225–236. [PubMed]
  • Gunics G, Farkas S, Motahashi N, Shah A, Harsukh G, Kawase M, Molnár J. Interaction between 3,5-diacetyl-dihydropyridines and ampicillin, and erythromycin on different E. coli strains. International Journal of Antimicrobial Agents. 2002;20:227–229. doi: 10.1016/S0924-8579(02)00159-0. [PubMed] [Cross Ref]
  • Gunics Gyöngyi, Motohashi Noboru, Amaral Leonard, Farkas Sandor, Molna Joseph. Interaction between antibiotics and non-conventional antibiotics on bacteria. International Journal of Antimicrobial Agents. 2000;14:239–242. doi: 10.1016/S0924-8579(00)00131-X. [PubMed] [Cross Ref]
  • Coutinho HDM, Costa JGM, Falcão-Silva VS, Lima EO, Siqueira-Júnior JP. Enhancement of the antibiotic activity against a multiresistant Escherichia coli by Mentha arvensis L. and chlorpromazine. Chemotherapy. 2008;54:328–330. doi: 10.1159/000151267. [PubMed] [Cross Ref]
  • Hemaiswarya SH, Kruthiventi AK, Doble M. Synergism between natural products and antibiotics against diseases. Phytomedicine. 2008;15:639–652. doi: 10.1016/j.phymed.2008.06.008. [PubMed] [Cross Ref]
  • Wagner H, Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine. 2009;16:97–110. doi: 10.1016/j.phymed.2008.12.018. [PubMed] [Cross Ref]

Articles from BMC Complementary and Alternative Medicine are provided here courtesy of BioMed Central

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...